Email

weborders@prabadincorp.com

Call us

+1 (786)-332-3938

  • Home
  • Blog
  • Latest Post
  • Product Catalog
b77e8639-129a-40c6-b128-527621a55c3a (1)
FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later because they can result in low amniotic fluid
Drug Test
  • February 20, 2025
By AdminPrabadin - 5 months ago
0

FDA warns that NSAID use at 20 weeks or later in pregnancy may cause serious kidney problems in an unborn baby, leading to low amniotic fluid levels. Do not take NSAIDs unless advised to do so by your health care professional.

Previous article

Initial safety trial results find increased risk of serious heart-related problems and cancer with arthritis and ulcerative colitis medicine Xeljanz, Xeljanz XR (tofacitinib)

Next article

FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems

AdminPrabadin
administrator

Related Articles

Drug Test

Hiding in Plain Sight: 7-OH Products

  • July 29, 2025
Drug Test

Field Science – Laboratory Manual

  • July 29, 2025
Drug Test

Laboratory Manual of Quality Policies (ISO 17025 Requirements)

  • July 29, 2025
© Copyright Barta 2018. Designed and Developed by Komarca Soft